D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$939M |
| 2 |
Netflix
NFLX
|
+$838M |
| 3 |
Micron Technology
MU
|
+$490M |
| 4 |
Affirm
AFRM
|
+$417M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$399M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$356M |
| 5 |
UnitedHealth
UNH
|
+$299M |
Sector Composition
| 1 | Technology | 28.8% |
| 2 | Consumer Discretionary | 15.68% |
| 3 | Healthcare | 9.51% |
| 4 | Financials | 8.37% |
| 5 | Communication Services | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Bankunited
BKU
$2.9B
| $7.34M | 0.01% |
226,482
-57,663
| -20% | -$1.87M |
|
902
Carnival PLC
CUK
$38.7B
| $7.32M | 0.01% |
434,303
+263,208
| +154% | +$4.44M |
|
903
N-able
NABL
$1.53B
| $7.29M | 0.01% |
549,970
+62,516
| +13% | +$828K |
|
904
Orion
OEC
$570M
| $7.28M | 0.01% |
262,358
-28,631
| -10% | -$794K |
|
905
TriNet
TNET
$3.3B
| $7.26M | 0.01% |
61,036
-6,912
| -10% | -$822K |
|
906
Guess, Inc.
GES
$868M
| $7.23M | 0.01% |
313,655
+141,552
| +82% | +$3.26M |
|
|
RPT
907
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $7.23M | 0.01% |
563,519
+302,429
| +116% | +$3.88M |
|
908
Landstar System
LSTR
$4.5B
| $7.21M | 0.01% |
37,218
-27,963
| -43% | -$5.42M |
|
909
ResMed
RMD
$39.6B
| $7.14M | 0.01% |
41,483
-615,850
| -94% | -$106M |
|
910
Dynavax Technologies
DVAX
$1.14B
| $7.13M | 0.01% |
510,257
-309,353
| -38% | -$4.32M |
|
911
Groupon
GRPN
$916M
| $7.13M | 0.01% |
555,106
+518,887
| +1,433% | +$6.66M |
|
912
Baxter International
BAX
$12.3B
| $7.05M | 0.01% |
182,351
-584,377
| -76% | -$22.6M |
|
913
IAMGOLD
IAG
$6.35B
| $7.04M | 0.01% |
2,784,348
-441,915
| -14% | -$1.12M |
|
914
Clearwater Analytics
CWAN
$5.88B
| $7.03M | 0.01% |
350,999
+248,643
| +243% | +$4.98M |
|
915
Delek US
DK
$1.79B
| $7M | 0.01% |
271,264
+36,704
| +16% | +$947K |
|
916
John Wiley & Sons Class A
WLY
$2.21B
| $7M | 0.01% |
220,444
+24,503
| +13% | +$778K |
|
917
Intapp
INTA
$3.65B
| $6.99M | 0.01% |
183,872
-92,301
| -33% | -$3.51M |
|
918
Pacira BioSciences
PCRX
$1.2B
| $6.95M | 0.01% |
206,016
+48,954
| +31% | +$1.65M |
|
919
Edison International
EIX
$21.4B
| $6.92M | 0.01% |
96,851
+2,093
| +2% | +$150K |
|
920
SpartanNash
SPTN
$900M
| $6.91M | 0.01% |
301,040
-51,247
| -15% | -$1.18M |
|
921
Newmont
NEM
$87.5B
| $6.89M | 0.01% |
166,353
-346,968
| -68% | -$14.4M |
|
922
Belden
BDC
$5.15B
| $6.88M | 0.01% |
89,122
+53,839
| +153% | +$4.16M |
|
923
ESAB
ESAB
$6.9B
| $6.88M | 0.01% |
79,436
+57,166
| +257% | +$4.95M |
|
924
Tenet Healthcare
THC
$16.9B
| $6.85M | 0.01% |
90,614
-119,849
| -57% | -$9.06M |
|
925
TechTarget
TTGT
$404M
| $6.84M | 0.01% |
196,200
+6,025
| +3% | +$210K |
|